Fig. 7From: Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasisThe local response maintenance rate of GEF with RT group and GEF w/o RT group. The local response maintenance rate at 1 year was 92% and 54%, respectively (log-rank test p < 0.001)Back to article page